{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:37Z","timestamp":1794047557188,"version":"4.8.0"},"reference-count":0,"publisher":"Ferrata Storti Foundation (Haematologica)","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Geriatric assessment is recommended for older adults undergoing cancer treatment, but the best frailty assessment tools for blood cancers are unknown. We conducted a prospective cohort study of three gold standard approaches: the cumulative deficit index, phenotypic frailty, and four-meter gait speed. From February 2015 to January 2025, a research assistant approached patients aged \u2265 73 years attending new consultations for leukemia, lymphoma, and multiple myeloma. A total of 1011 patients underwent frailty assessment with a median age of 78 years (IQR, 76-82 years) and a median follow-up among survivors of 43 months (IQR, 18-74 months). For example, when classified by phenotypic frailty, 11% were frail, 59% pre-frail, and 30% robust; using this tool, frail patients lived 24 months compared to 92 months among the robust. While frailty classification varied across measures, all three tools were associated with mortality in a dose-dependent manner, independent of age and sex (cumulative deficit index: ref=robust, pre-frail HR 1.86 [95% CI 1.54, 2.26]; frail HR 2.42 [1.85, 3.17]; phenotypic frailty: ref=robust; pre-frail HR 1.88 [1.50, 2.37], frail HR 3.01, [2.22, 4.07]); gait speed: ref=\u2265 0.8 m\/s; 0.6 to &lt; 0.8 m\/s HR 1.44 [1.18, 1.76], &lt; 0.6 m\/s HR 2.06 [1.61, 2.63]). Associations were similar when analyzed by disease clinic; cumulative deficit further stratified risk in patients assessed by phenotypic frailty and gait speed. Our findings provide a new benchmark on frailty and its impact on survival in older adults with blood cancers, with care delivery implications for operationalization in clinical practice and research.<\/jats:p>","DOI":"10.3324\/haematol.2025.300233","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:33:13Z","timestamp":1776929593000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and impact of frailty assessed using standard geriatrics tools in older adults with blood cancers"],"prefix":"10.3324","author":[{"given":"Clark","family":"DuMontier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy T.","family":"Hshieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameya","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Mozessohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2026,4,23]]},"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/14141\/80196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/14141\/80196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:14:00Z","timestamp":1794046440000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/14141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.300233","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}